Who is sponsoring NCT02682290?

NCT02682290 is sponsored by University Hospital, Grenoble.

What drugs are being tested in NCT02682290?

Interventions in NCT02682290: Expectoration and measurement of sputum rheological properties.

What condition does NCT02682290 study?

NCT02682290 studies COPD, Asthma, Cystic Fibrosis.

Is NCT02682290 still recruiting?

NCT02682290 is currently completed. Last updated 27 October 2017.

Last reviewed 2017-10-27 · How we verify

NCT02682290: RHEOMUCO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Rheological Parameters of Human Sputum.

Completed NA Last updated 27 October 2017

What this trial tests

NA trial testing Expectoration and measurement of sputum rheological properties in COPD in 45 participants. Completed in 4 July 2017.

Timeline

3 March 2016

Primary endpoint
4 July 2017

4 July 2017

Quick facts

Lead sponsor	University Hospital, Grenoble
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	45
Start date	3 March 2016
Primary completion	4 July 2017
Estimated completion	4 July 2017
Sites	1 location across France

Drugs / interventions tested

Expectoration and measurement of sputum rheological properties

Conditions studied

COPD — all drugs for COPD →
Asthma — all drugs for Asthma →
Cystic Fibrosis — all drugs for Cystic Fibrosis →

Sponsor

University Hospital, Grenoble

Who can join

18 and older, any sex, with COPD or Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a proof of concept study. The aim of this study is to assess a device measuring rheological properties of human sputum of four populations : * 10 patients with Broncho Chronic Obstructive Pulmonary Disease (COPD) * 10 patients with asthma * 10 patients with cystic fibrosis * 10 healthy volunteers.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Dornase alfa for cystic fibrosis.
Yang C, Montgomery M. · · 2018 · cited 63× · PMID 30187450 · DOI 10.1002/14651858.cd001127.pub4
Rheological analysis of sputum from patients with chronic bronchial diseases.
Patarin J, Ghiringhelli É, Darsy G, Obamba M, et al · · 2020 · cited 43× · PMID 32973305 · DOI 10.1038/s41598-020-72672-6
Dornase alfa for cystic fibrosis.
Yang C, Montgomery M. · · 2021 · cited 39× · PMID 33735508 · DOI 10.1002/14651858.cd001127.pub5

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02682290 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 27 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02682290.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing